MZManja Zec

Manja Zec

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manja Zec has a total of 232 co-authors. Here are the top co-authors by number of shared publications:

  • Jasmina Debeljak-Martačić

    Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr Subotića 4, 11000 Belgrade, Serbia

    6 shared publications
  • Maria Glibetic

    Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, Belgrade 11000, Serbia

    6 shared publications
  • Aleksandra Konić-Ristić

    Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade, Belgrade, Serbia

    5 shared publications
  • Milica Zeković

    Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Tadeusa Koscuska 1, 11000 Belgrade, Serbia

    5 shared publications
  • Tatjana Srdic-Rajic

    Institute for Oncology and Radiology of Serbia, Department of Experimental Oncology, Belgrade, Serbia

    5 shared publications
  • Aleksandra Stanković

    Laboratory for Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia

    4 shared publications

Latest Publications

  • Open Access

    The Influence of Fatty Acid Expression Methods on Associations with Cardiometabolic Biomarkers: Evidence from NHANES 2011–2012

    by Brian Hallmark, Manja M. Zec, Laurel Johnstone, Carrie S. Standage-Beier, Susan Sergeant, Justin M. Snider, J. Thomas Brenna, Floyd H. Chilton

    Background/Objectives: Fatty acids (FAs) are critical mediators of human physiology, yet associations between dietary intake, circulating FA levels, and health outcomes remain debated. Circulating FAs are typically reported as a percentage of total FA (% total), whereas absolute concentrations are measured infrequently. Although mathematically related, these metrics provide distinct information. NHANES 2011–2012 uniquely provided serum FA concentrations, enabling direct comparison of concentration and % total within the same individuals. Methods: Serum FAs measured by electron capture negative-ion mass spectrometry in NHANES 2011–2012 were expressed as both absolute concentrations (µmol/L) and % total. Associations of each representation with lipid and non-lipid cardiometabolic biomarkers were evaluated and compared with total FA concentrations. Results: For multiple FAs and biomarkers, the direction of association differed depending on whether FAs were expressed as concentration or % total. These reversals occurred when total FAs varied more strongly with the biomarker than the individual FA concentration, allowing a FA to increase in absolute concentration while decreasing as a percentage of the total FA pool. Reversals were observed for several major FAs, including linoleic acid (LA), arachidonic acid (ARA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), and stearic acid (SA). Total FA concentrations were strongly associated with most biomarkers. Conclusions: FA concentrations and % total are complementary, not interchangeable, measures that capture distinct aspects of circulating FA biology. Associations with outcomes can be in opposite directions when the total plasma FA pool varies. These differences reflect underlying mathematical and biological relationships rather than methodological error. Future studies should routinely evaluate the total FA pool size alongside FA composition. Examining both representations alongside total FA can help distinguish changes in absolute FA abundance from changes in relative composition and provide a more complete interpretation of FA associations.

  • Open Access

    The Impact of Fatty Acid Reporting Methods on Associations with Cardiometabolic Biomarkers

    by Brian R Hallmark, Manja M. Zec, Laurel M Johnstone, Carrie S. Standage-Beier, Susan Sergeant, Justin Snider, J. Thomas Brenna, Floyd H. Chilton

    Background: Global dietary guidelines for polyunsaturated fatty acids (PUFAs), especially linoleic acid (LA) and its metabolite arachidonic acid (ARA), remain debated. Almost all research to date has used fatty acid (FA) data expressed as percent of total FA (% total). Objective: The objective of this study was to determine whether expressing fatty acid (FA) data as % of total or as absolute concentrations alters associations with clinical biomarkers. Methods: Serum FA data obtained via electron capture negative-ion mass spectrometry was obtained from NHANES. Each FA was expressed both as % total and absolute concentration (µmol/L). Associations were examined between individual and total FAs and a panel of lipid and non-lipid biomarkers, including total cholesterol, LDL-C, HDL-C, triglycerides, blood pressure, body mass index, waist circumference, glucose, and insulin. Results: Associations between LA and clinical biomarkers including triglycerides, cholesterol, HDL-C, BMI, glucose, and insulin, reversed direction depending on whether LA was expressed as % total or as a concentration. Similar reversals were observed for ARA, DHA, DPA, and stearic acid. Increases in total FA levels were accompanied by decreases in % total of several PUFAs and HUFAs, despite rising absolute concentrations. Total FA was positively associated, often strongly, with nine clinical markers and negatively associated with HDL-C. Conclusions: Expression format significantly impacts observed FA associations. Reliance on % total FA values alone may misrepresent true associations between individual FAs and clinical endpoints, especially when the total fatty acid pool also changes size. To develop effective dietary guidance or clinical recommendations, it is essential to consider the underlying FA biology and total FA pool size when determining whether % total or absolute FA concentrations are more appropriate.

  • Open Access

    Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults

    by Madhur Wyatt, Ankan Choudhury, Gabriella Von Dohlen, Jeffery L. Heileson, Jeffrey S. Forsse, Sumudu Rajakaruna, Manja Zec, Malak M. Tfaily, Leigh Greathouse

    Evidence indicates that both vitamin D and the gut microbiome are involved in the process of colon carcinogenesis. However, it is unclear what effects supplemental vitamin D 3 has on the gut microbiome and its metabolites in healthy adults. We conducted a double-blind, randomized, placebo-controlled trial to identify the acute and long-term microbiota structural and metabolite changes that occur in response to a moderate dose (4,000 IU) of vitamin D 3 for 12 weeks in healthy adults. Our results demonstrated a significant increase in serum 25-hydroxy-vitamin D (25(OH)D) in the treatment group compared to placebo ( P < 0.0001). Vitamin D 3 significantly increased compositional similarity ( P < 0.0001) in the treatment group, and enriched members of the Bifidobacteriaceae family. We also identified a significant inverse relationship between the percent change in serum 25(OH)D and microbial stability in the treatment group ( R = −0.52, P < 0.019). Furthermore, vitamin D 3 supplementation resulted in notable metabolic shifts, in addition to resulting in a drastic rewiring of key gut microbial-metabolic associations. In conclusion, we show that a moderate dose of vitamin D 3 among healthy adults has unique acute and persistent effects on the fecal microbiota, and suggest novel mechanisms by which vitamin D may affect the host-microbiota relationship. IMPORTANCE: Preventative measures to reduce the rise in early-onset colorectal cancer are of critical need. Both vitamin D, dietary and serum levels, and the gut microbiome are implicated in the etiology of colorectal cancer. By understanding the intimate relationship between vitamin D, the gut microbiome, and its metabolites, we may be able to identify key mechanisms that can be targeted for intervention, including inflammation and metabolic dysfunction. Furthermore, the similarity of vitamin D to cholesterol, which is metabolized by the gut microbiome, gives precedence to its ability to produce metabolites that can be further studied and leveraged for controlling colorectal cancer incidence and mortality.


  • Open Access

    Metabolically Healthy Overweight and Obesity, Transition to Metabolically Unhealthy Status and Cognitive Function: Results from the Framingham Offspring Study

    by Matina Kouvari, Nathan M. D’cunha, Thomas Tsiampalis, Manja Zec, Domenico Sergi, Nikolaj Travica, Wolfgang Marx, Andrew J. McKune, Demosthenes B. Panagiotakos, Nenad Naumovski

    Aims: To evaluate the association between metabolically healthy overweight/obesity (MHO) status and longitudinal cognitive function while also considering the stability of the condition. Methods: In total, 2892 participants (mean age 60.7 (9.4) years) from Framingham Offspring Study completed health assessments every four years since 1971. Neuropsychological testing was repeated every four years starting from 1999 (Exam 7) to 2014 (Exam 9) (mean follow-up: 12.9 (3.5) years). Standardized neuropsychological tests were constructed into three factor scores (general cognitive performance, memory, processing speed/executive function). Healthy metabolic status was defined as the absence of all NCEP ATP III (2005) criteria (excluding waist circumference). MHO participants who scored positively for one or more of NCEP ATPIII parameters in the follow-up period were defined as unresilient MHO. Results: No significant difference on the change in cognitive function over time was observed between MHO and metabolically healthy normal weight (MHN) individuals (all p > 0.05). However, a lower processing speed/executive functioning scale score was observed in unresilient MHO participants compared to resilient MHO participants (β = −0.76; 95% CI = −1.44, −0.08; p = 0.030). Conclusions: Retaining a healthy metabolic status over time represents a more important discriminant in shaping cognitive function compared to body weight alone.


  • Open Access

    Dietary patterns, caloric restrictions for management of cardiovascular disease and cancer; a brief review

    by Heidi Bochenek, Irena Krga, Domenico Sergi, Matina Kouvari, Manja Zec, Nenad Naumovski

    Cardiovascular disease (CVD) and cancers are overall still identified as the two most prevalent non-communicable diseases globally. Their prevention and potential reversal (in particular CVD risk) was seen effective with the modification of dietary intake that was applied in several different populations. Although the findings from epidemiological studies provide support that adhering to dietary patterns such as the Mediterranean diet can reduce incidence and prevalence of CVD and some forms of cancer, the mechanistic aspects of disease modulation associated with both diseases can be seen in dietary management. Several studies have already explored the potential modes of action of certain nutrients in well controlled large clinical trials. However, the clinical trials designed to determine the effects of adhering to a particular diet are relatively hard to conduct and these studies are faced with several obstacles particularly in the populations that are identified with a high risk of CVD or different cancers. Therefore, it is important to understand potential underlying and shared mechanisms of action and to explore how healthy dietary patterns may modulate the occurrence, initiation, and progression of such diseases. The aim of this review is to summarise and conceptualize the current understanding relating to healthy dietary patterns, and briefly discuss the opportunities that epigenetic research may bring and how it may assist to further interpret epidemiological and clinical evidence.


  • Open Access

    Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review

    by Matina Kouvari, Nathan M. D’cunha, Nikolaj Travica, Domenico Sergi, Manja Zec, Wolfgang Marx, Nenad Naumovski

    Background: This narrative review presents the association between metabolic syndrome (MetS), along with its components, and cognition-related disorders, as well as the potential reversal role of diet against cognitive impairment by modulating MetS. Methods: An electronic research in Medline (Pubmed) and Scopus was conducted. Results: MetS and cognitive decline share common cardiometabolic pathways as MetS components can trigger cognitive impairment. On the other side, the risk factors for both MetS and cognitive impairment can be reduced by optimizing the nutritional intake. Clinical manifestations such as dyslipidemia, hypertension, diabetes and increased central body adiposity are nutrition-related risk factors present during the prodromal period before cognitive impairment. The Mediterranean dietary pattern stands among the most discussed predominantly plant-based diets in relation to cardiometabolic disorders that may prevent dementia, Alzheimer’s disease and other cognition-related disorders. In addition, accumulating evidence suggests that the consumption of specific dietary food groups as a part of the overall diet can improve cognitive outcomes, maybe due to their involvement in cardiometabolic paths. Conclusions: Early MetS detection may be helpful to prevent or delay cognitive decline. Moreover, this review highlights the importance of healthy nutritional habits to reverse such conditions and the urgency of early lifestyle interventions.


  • Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality

    by Justin M. Snider, Jeehyun Karen You, Xia Wang, Ashley J. Snider, Brian Hallmark, Manja M. Zec, Michael C. Seeds, Susan Sergeant, Laurel Johnstone, Qiuming Wang, et al.

    There is an urgent need to identify the cellular and molecular mechanisms responsible for severe COVID-19 that results in death. We initially performed both untargeted and targeted lipidomics as well as focused biochemical analyses of 127 plasma samples and found elevated metabolites associated with secreted phospholipase A2 (sPLA2) activity and mitochondrial dysfunction in patients with severe COVID-19. Deceased COVID-19 patients had higher levels of circulating, catalytically active sPLA2 group IIA (sPLA2-IIA), with a median value that was 9.6-fold higher than that for patients with mild disease and 5.0-fold higher than the median value for survivors of severe COVID-19. Elevated sPLA2-IIA levels paralleled several indices of COVID-19 disease severity (e.g., kidney dysfunction, hypoxia, multiple organ dysfunction). A decision tree generated by machine learning identified sPLA2-IIA levels as a central node in the stratification of patients who died from COVID-19. Random forest analysis and least absolute shrinkage and selection operator–based (LASSO-based) regression analysis additionally identified sPLA2-IIA and blood urea nitrogen (BUN) as the key variables among 80 clinical indices in predicting COVID-19 mortality. The combined PLA-BUN index performed significantly better than did either one alone. An independent cohort (n = 154) confirmed higher plasma sPLA2-IIA levels in deceased patients compared with levels in plasma from patients with severe or mild COVID-19, with the PLA-BUN index–based decision tree satisfactorily stratifying patients with mild, severe, or fatal COVID-19. With clinically tested inhibitors available, this study identifies sPLA2-IIA as a therapeutic target to reduce COVID-19 mortality.


  • Open Access

    Polyphenol-Rich Aronia melanocarpa Juice Consumption Affects LINE-1 DNA Methylation in Peripheral Blood Leukocytes in Dyslipidemic Women

    by Ljiljana Stojković, Manja Zec, Maja Zivkovic, Maja Bundalo, Maja Bošković, Marija Glibetić, Aleksandra Stankovic

    Cardiovascular disease (CVD) is associated with alterations in DNA methylation and polyunsaturated fatty acid (PUFA) profile, both modulated by dietary polyphenols. The present parallel, placebo-controlled study (part of the original clinical study registered as NCT02800967 at www.clinicaltrials.gov) aimed to determine the impact of 4-week daily consumption of polyphenol-rich Aronia melanocarpa juice (AMJ) treatment on Long Interspersed Nucleotide Element-1 (LINE-1) methylation in peripheral blood leukocytes and on plasma PUFAs, in subjects (n = 54, age range of 40.2 ± 6.7 years) at moderate CVD risk, including an increased body mass index, central obesity, high normal blood pressure, and/or dyslipidemia. The goal was also to examine whether factors known to affect DNA methylation (folate intake levels, MTHFR C677T gene variant, anthropometric and metabolic parameters) modulated the LINE-1 methylation levels upon the consumption of polyphenol-rich aronia juice. Experimental analysis of LINE-1 methylation was done by MethyLight method. MTHFR C677T genotypes were determined by the polymerase chain reaction–restriction fragment length polymorphism method, and folate intake was assessed by processing the data from the food frequency questionnaire. PUFAs were measured by gas–liquid chromatography, and serum lipid profile was determined by using Roche Diagnostics kits. The statistical analyses were performed using Statistica software package. In the comparison after vs. before the treatment period, in dyslipidemic women (n = 22), we observed significant decreases in LINE-1 methylation levels (97.54 ± 1.50 vs. 98.39 ± 0.86%, respectively; P = 0.01) and arachidonic acid/eicosapentaenoic acid ratio [29.17 ± 15.21 vs. 38.42 (25.96–89.58), respectively; P = 0.02]. The change (after vs. before treatment) in LINE-1 methylation directly correlated with the presence of MTHFR 677T allele, average daily folate intake, and the change in serum low-density lipoprotein cholesterol but inversely correlated with the change in serum triacylglycerols (R = 0.72, R2 = 0.52, adjusted R2 = 0.36, P = 0.03). The current results imply potential cardioprotective effects of habitual polyphenol-rich aronia juice consumption achieved through the modifications of DNA methylation pattern and PUFAs in subjects at CVD risk, which should be further confirmed. Hence, the precision nutrition-driven modulations of both DNA methylation and PUFA profile may become targets for new approaches in the prevention of CVD.


  • Fructose‐rich diet and walnut supplementation differently regulate rat hypothalamic and hippocampal glucose transporters expression

    by Tamara Dakic, Iva Lakic, Manja Zec, Marija Takic, Mojca Stojiljkovic, Tanja Jevdjovic

    BACKGROUND: Nutritional modulations may be considered a strategy to protect mental health. Neuronal homeostasis is highly dependent on the availability of glucose, which represents the primary energy source for the brain. In this study, we evaluated the effects of walnut intake and fructose‐rich diet on the expression of glucose transporters (GLUTs) in two rat brain regions: hypothalamus and hippocampus.RESULTS: Our results show that walnut supplementation of fructose‐fed animals restored the hypothalamic content of GLUT1 and GLUT3 protein. Furthermore, walnut intake did not affect increased hypothalamic GLUT2 content upon fructose consumption. These effects were accompanied by distinctive alterations of hippocampal GLUTs levels. Specifically, walnut intake increased GLUT1 content, whereas GLUT2 protein was decreased within the rat hippocampus after both individual and combined treatments.CONCLUSION: Overall, our study suggests that walnut supplementation exerted modulatory effects on the glucose transporters within specific brain regions in the presence of developed metabolic disorder. © 2021 Society of Chemical Industry.


  • Open Access

    Is There a FADS2-Modulated Link between Long-Chain Polyunsaturated Fatty Acids in Plasma Phospholipids and Polyphenol Intake in Adult Subjects Who Are Overweight?

    by Manja M. Zec, Irena Krga, Ljiljana Stojković, Maja Živković, Biljana Pokimica, Aleksandra Stanković, Maria Glibetic

    Dietary polyphenols promote cardiometabolic health and are linked with long-chain polyunsaturated fatty acids in plasma phospholipids (LC-PUFA). The FADS2 polymorphisms are associated with LC-PUFA metabolism and overweight/obesity. This 4-week study examined the link between polyphenol intake, FADS2 variants (rs174593, rs174616, rs174576) and obesity in 62 overweight adults (BMI ≥ 25), allocated to consume 100 mL daily of either: Aronia juice, a rich source of polyphenols, with 1177.11 mg polyphenols (expressed as gallic acid equivalents)/100 mL (AJ, n = 22), Aronia juice with 294.28 mg polyphenols/100 mL (MJ, n = 20), or nutritionally matched polyphenol-lacking placebo as a control (PLB, n = 20). We analyzed LC-PUFA (% of total pool) by gas chromatography and FADS2 variants by real-time PCR. Four-week changes in LC-PUFA, BMI, and body weight were included in statistical models, controlling for gender and PUFA intake. Only upon AJ and MJ, the presence of FADS2 variant alleles affected changes in linoleic, arachidonic, and eicosapentaenoic acid (EPA). Upon MJ treatment, changes in EPA were inversely linked with changes in BMI (β= −0.73, p = 0.029) and weight gain (β= −2.17, p = 0.024). Only in subjects drinking AJ, the link between changes in EPA and anthropometric indices was modified by the rs174576 variant allele. Our results indicate the interaction between FADS2, fatty acid metabolism, and polyphenol intake in overweight subjects.